PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24296301-9	2014	Antioxidant treatments (deferoxamine mesylate, (+-)alpha-tocopherol, or tempol) suppressed BDE-47-stimulated IL-6 release by 54.1%, 56.3% and 37.7%, respectively, implicating a role for ROS in the regulation of inflammatory pathways in HTR-8/SVneo cells.	Deferoxamine	24-45	interleukin 6	Homo sapiens	109-113